Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Nasdaq's Growth Initiatives Impress Amid Escalating Costs

Published 08/31/2016, 10:49 PM
Updated 07/09/2023, 06:31 AM

On Sep 1, we issued an updated research report on Nasdaq Inc. (NASDAQ:NDAQ) .

Nasdaq remains focused on growth via organic initiatives as well as acquisitions that extend entry and cross-selling opportunities in new markets at a low-cost with a highly flexible platform. The latest buyouts of International Securities Exchange and Boardvantage are in tandem with this strategy. Notably, the company achieved the first $10 million of synergies from acquisitions in the second quarter. This was the company’s first step toward a total synergy target of $40 million.

The company displays its prudence by accelerating its non-transaction revenue base, which includes technology, listing and information revenues. This has been fueling organic growth for the securities exchange. In fact, management projects consistent mid-single-digit organic growth over the next three to five years.

Nasdaq focuses on boosting operating leverage through efficient business management. This, in turn, enhances its ability to invest in new business initiatives, thereby making way for healthy long-term organic growth.

Nasdaq’s healthy balance sheet and cash position are supported by its robust operational performance. This, helps the company engage in effective capital deployment to enhance shareholders’ value.

Based on the positives, the Zacks Consensus Estimate has been witnessing upward revisions as most of the estimates were revised higher in the last 60 days. The expected long-term earnings growth is currently pegged at 9.9%.

However, escalating expenses pose risks to operating leverage, margins and growth prospects. Also, high debts, weak top line and intense competition raise concerns. To account for the anticipated impact of the acquisition of International Securities Exchange, management has raised the operating expense guidance by $35 million to the range of $1.22–$1.27 billion in 2016. Also, weak cash equity trading revenues as well as sluggish derivative trading and clearing revenues in both the U.S. and Europe are concerns.

Zacks Rank and Stocks to Consider

Currently, Nasdaq has a Zacks Rank #3 (Hold). Some better-ranked securities exchanges are Bats Global Markets (NYSE:BATS) , CME Group Inc. (NASDAQ:CME) and MarketAxess Holdings Inc. (NASDAQ:MKTX) . Each of these carry Zacks Rank #2 (Buy).

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Confidential from Zacks

Beyond this Analyst Blog, would you like to see Zacks' best recommendations that are not available to the public? Our Executive VP, Steve Reitmeister, knows when key trades are about to be triggered and which of our experts has the hottest hand. Click to see them now>>




CME GROUP INC (CME): Free Stock Analysis Report

NASDAQ INC (NDAQ): Free Stock Analysis Report

MARKETAXESS HLD (MKTX): Free Stock Analysis Report

BATS GLOBAL MKT (BATS): Free Stock Analysis Report

Original post

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.